Can trifluoperazine protect mitochondria against reactive oxygen species-induced damage? R. De Souza PereiraM. Hermes-Lima OriginalPaper Pages: 281 - 284
Pharmacokinetic-pharmacodynamic modelling of DP-1904, a novel thromboxane synthetase inhibitor in rabbits, based on an indirect response model N. X. ZhengH. SatoI. Horikoshi OriginalPaper Pages: 285 - 293
Bioavailability study of paracetamol tablets in saliva and urine P. RetacoM. GonzálezM. G. Volonté OriginalPaper Pages: 295 - 300
Dextromethorphan metabolism in Jordanians: Dissociation of dextromethorphan O-demethylation from debrisoquine 4-hydroxylation Y. M. IrshaidH. F. Al-HadidiN. M. Rawashdeh OriginalPaper Pages: 301 - 307
Metabolic ratios of four probes of CYP2D6 in Turkish subjects: A cross-over study A. BozkurtN. E. BaşçiS. O. Kayaalp OriginalPaper Pages: 309 - 314
Comparative study of the biotransformation of bepridil analogs in isolated liver cells from one rat. Relationships between structure and in vitro liver toxicity E. DamatteM. J. GalmierJ. L. Chabard OriginalPaper Pages: 315 - 325
The effect of furazolidone and furaltadone on drug metabolism in rats B. H. AliM. O. M. TaniraA. K. Bashir OriginalPaper Pages: 327 - 332
Comparative pharmacokinetics of Aspegic 1000 mg i.v. versus 1000 mg i.m. thrice daily B. NiaJ. M. Vergnaud OriginalPaper Pages: 333 - 338
Disposition of3H-labelled buserelin continuously infused into rats N. HeinrichE. AlbrechtH. Berger OriginalPaper Pages: 345 - 350